<owl:Class xmlns="https://folio.openlegalstandard.org/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:v1="http://www.loc.gov/mads/rdf/v1#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:folio="https://folio.openlegalstandard.org/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" rdf:about="https://folio.openlegalstandard.org/R77fqr5miBDHdl6nvSiWPiN">
  <rdfs:subClassOf rdf:resource="https://folio.openlegalstandard.org/R7M8wW11LJaLtWjQS7DmTQH"/>
  <rdfs:label>Myasthenia Gravis</rdfs:label>
  <skos:altLabel>Autoimmune Neuromuscular Disorder</skos:altLabel>
  <skos:altLabel>MG</skos:altLabel>
  <skos:definition>Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. It occurs when the immune system produces antibodies that interfere with the communication between nerves and muscles, leading to muscle weakness, especially after periods of activity.</skos:definition>
</owl:Class>
